Publication | Closed Access
Intravenous Ribavirin Is a Safe and Cost-effective Treatment for Respiratory Syncytial Virus Infection After Lung Transplantation
139
Citations
25
References
2005
Year
Lung TransplantationCost-effective TreatmentAntiviral Drug DevelopmentAntiviral TherapyVirologyInfectious Respiratory DiseaseAntiviral DrugMedicineIntravenous RibavirinCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1